Skip to main content

Security report for roche.ch

Roche Schweiz · Healthcare · Switzerland

Low risk. 3 critical or high findings in GDPR outside view and SSL/TLS.

Security score

78/100

Risk levelLow

0–100, higher is better. How it is calculated

Roche Schweiz is a leading healthcare company specializing in innovative pharmaceuticals and diagnostic tests, serving millions of patients worldwide. The website reflects a mature digital presence with a modern tech stack based on Gatsby and React, ensuring fast performance and excellent mobile optimization. Security posture is strong with HTTPS, comprehensive security headers, and no visible vulnerabilities. Privacy compliance is well addressed with clear privacy and cookie policies, including GDPR adherence. Business credibility is high, supported by consistent branding, clear contact information, and trust indicators such as certifications and official corporate data. Overall, the website is professional, secure, and trustworthy, suitable for its enterprise healthcare audience.

Scanned

NIS2 and GDPR posture

GDPR outside view
53/ 100 · Medium
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

3 findings rated critical or high. Fix these first.

  1. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • High

      No Cookie Policy found

      GDPR requires clear information about cookie usage

      What to do: Add a dedicated cookie policy explaining cookie usage and purposes

    • High

      No Cookie Consent Banner found

      GDPR requires explicit consent for non-essential cookies

      What to do: Implement a cookie consent banner that appears on first visit

  2. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak SSL Key Length

      SSL certificate uses 256-bit key, which is considered weak

      What to do: Use at least 2048-bit RSA or 256-bit ECC key

      • CWE-326
      • OWASP A04:2025
      • Mozilla TLS: Mozilla Server Side TLS 6.0 intermediate: rsa_key_size 2048

Need hands-on remediation? Email guard@offseq.com

Keep watching roche.ch

This scan found 16 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. See sample alerts.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
75
Security headers
85
Email security
70
DNS health
85
Network security
100
GDPR outside view
53
Average
78

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

Roche Schweiz operates within the healthcare sector as part of the global Roche Holding AG. It targets healthcare professionals, patients, and partners in Switzerland, offering innovative medicines and diagnostic solutions. The business model is focused on research, development, and sales of pharmaceutical and diagnostic products. The company holds strong market positioning as a global leader with a long history since 1896. The website supports this with comprehensive content, certifications, and clear corporate information. Partnerships with marketing and video platforms like Marketo and Brightcove indicate a sophisticated marketing ecosystem. The presence of multiple subsidiaries and related domains reflects a complex corporate structure.

Security posture

The website demonstrates a high level of security maturity with enforced HTTPS, robust security headers, and secure form implementations. No exposed sensitive data or vulnerable libraries were detected in the HTML content. However, explicit security policies and incident response contacts are not publicly detailed, representing an area for improvement. The absence of a vulnerability disclosure or security.txt file suggests limited transparency in vulnerability management. Overall, the security posture is strong but could benefit from enhanced public security governance documentation.

Recommendations

  1. Publish a dedicated security policy page outlining security practices and commitments.
  2. Implement and publicize a vulnerability disclosure program or security.txt file to encourage responsible reporting.
  3. Add explicit incident response contact information to improve transparency and trust.
  4. Regularly audit third-party libraries and marketing tools to ensure no vulnerabilities are introduced.
  5. Enhance privacy policy details with explicit data retention and user rights information.

Contact details published on the site

Addresses
Legal name
F. Hoffmann-La Roche AG
Registration number
CH-270.3.004.646-7
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Roche Schweiz
Description
Heute entwickelt Roche innovative Medikamente und diagnostische Tests, die Millionen von Patientinnen und Patienten weltweit helfen
Key services
Innovative medicines, Diagnostic tests
Content quality
excellent
Branding
consistent

Technology

Stack
React, Gatsby, JavaScript, CSS
Frameworks
Gatsby
Platforms
Web
Performance
fast
Mobile
excellent
Accessibility
good
SEO
good

Security

Observed score
90/100
Good practices seen
  • HTTPS enforced
  • Security headers present
  • No exposed sensitive data in HTML
  • Secure forms with proper labeling and validation

Analytics and tracking

Services
Marketo
Tracking level
moderate
Privacy practices
good

Advertising

Tracking pixels
Marketo
Marketing tools
Marketo
Transparency
basic

Site quality

Design
excellent
User experience
excellent
Content relevance
excellent
Navigation
excellent
Professionalism
excellent
Trustworthiness
high

Key observations

  1. Website is fully accessible and professionally designed.
  2. Content is comprehensive and targeted to healthcare stakeholders.
  3. Strong corporate branding and consistent messaging.
  4. Good security posture with HTTPS and security headers.
  5. Privacy and cookie policies are present and GDPR compliant.
  6. No suspicious or malicious indicators detected.
  7. Use of modern web technologies and frameworks.
  8. Contact information is clear and includes multiple channels.
Technical notes

Notes

The website uses a modern React-based framework (Gatsby) for static site generation, contributing to fast load times and good SEO. The CSS and JavaScript are well structured, and the site is mobile optimized with responsive design. Accessibility features such as focus outlines and ARIA roles are present, supporting usability for diverse users. The use of third-party marketing tools like Marketo and Brightcove is integrated carefully without compromising performance. Hosting details are not explicit but likely corporate or cloud-based. Overall, the technical infrastructure is robust, scalable, and aligned with enterprise standards.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with roche.ch. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review roche.ch.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.